Active substanceNatamycinNatamycin
Similar drugsTo uncover
  • Natamycin
    suppositories the vagina. 
    R-PHARM, CJSC     Russia
  • Pimafucin®
    suppositories the vagina. 
    Astellas Farma Europe BV     Netherlands
  • Pimafucin®
    cream externally 
    Astellas Farma Europe BV     Netherlands
  • Pimafucin®
    pills inwards 
    Astellas Farma Europe BV     Netherlands
  • Primafungin®
    suppositories the vagina. 
    AVEKSIMA, JSC     Russia
  • Ecofucin®
    suppositories the vagina. 
    AVVA RUS, OJSC     Russia
  • Dosage form: & nbspcream for external use
    Composition:

    1 g of cream contains:

    Active substances: natamycin 20 mg

    Excipients: cetyl ether wax, decyl oleate (cetyl V), sodium lauryl sulfate, propylene glycol, propyl parahydroxybenzoate, methyl parahydroxybenzoate, cetostearyl alcohol, purified water.

    Description:

    Cream from white to light yellow color.

    Pharmacotherapeutic group:Antifungal agent
    ATX: & nbsp

    G.01.A.A.02   Natamycin

    Pharmacodynamics:

    Natamycin, the active substance of the drug, is an antifungal polyene antibiotic of fungicidal action. Natamycin binds the sterols of cell membranes, violating their integrity and function, which leads to the death of microorganisms. Most pathogenic yeast fungi are sensitive to natamycin, especially Candida albicans, some protozoa (T.vaginalis). Dermatophytes are less sensitive.Resistance to natamycin among yeast fungi is not found in clinical practice.

    Pharmacokinetics:

    With external and topical application is almost not absorbed through intact skin and mucous membranes.

    Indications:

    Fungal diseases of the skin and mucous membranes, caused by drug-susceptible pathogens, including:

    - vulvitis, vulvovaginitis, balanoposthitis, caused mainly by fungi Candida;

    - candidiasis of skin and nails;

    - external otitis, either primarily caused by fungi, or complicated by candidiasis;

    - dermatomycosis.

    Contraindications:

    - Hypersensitivity to the components of the drug.

    Carefully:not described
    Pregnancy and lactation:Pimafucin can be used during pregnancy and lactation. There is no evidence of adverse effects of the drug on the fetus.
    Dosing and Administration:

    When vulvitis, vulvovaginitis, balanoposthitis the cream is applied to the affected areas once or several times a day. With persistent flow vulvitis, vulvovaginitis, caused by Candida albicans In addition, Pimafucin is given in the form of tablets or vaginal suppositories.

    When dermatomycosis (incl.candidiasis of skin and nails, diaper rash in children) the cream is applied to the affected surface of the skin and nails 1 or more (up to 4) once a day.

    When mycosis of external auditory canal The affected surface is lubricated with cream 1 or several (up to 4) once a day. Before using the drug, the ear is cleaned. After applying the drug in the auditory canal, place the turunda from a natural material (cotton, wool).

    The duration of the course of treatment is set individually. After the disappearance of the symptoms of the disease is recommended to continue treatment a few more days.

    Side effects:Rarely, slight irritation, a burning sensation in the place of application of the drug is possible.
    Overdose:

    No cases of an overdose of Pimafucin were reported.

    Interaction:

    There is no data on the drug drug interaction.

    Special instructions:not described
    Effect on the ability to drive transp. cf. and fur:not described
    Form release / dosage:

    Cream for external use 2% in tubes of aluminum or plastic for 30 g. Together with instructions for use in a pack of cardboard.

    Packaging:Tubes aluminum (1) -tacks, cardboard
    Tubes plastic (1) -tacks, cardboard
    Storage conditions:

    At a temperature not higher than 25 ° C, out of the reach of children.

    Shelf life:4 years. Do not use after expiry date.
    Terms of leave from pharmacies:Without recipe
    Registration number:П N013552 / 02
    Date of registration:09.10.2008
    The owner of the registration certificate:Astellas Farma Europe BVAstellas Farma Europe BV Netherlands
    Manufacturer: & nbsp
    Representation: & nbspASTELLAS PHARMA YUROP BV ASTELLAS PHARMA YUROP BV Netherlands
    Information update date: & nbsp26.02.2014
    Illustrated instructions
      Instructions
      Up